Arbutus Biopharma (ABUS) News
NASDAQ: ABUSHealth CareBiotechnology: Pharmaceutical PreparationsUSD
4.18-0.11 (-2.56%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
ABUS news summary
We found 1 recent headline mentioning Arbutus Biopharma (ABUS): 0 in the past week and 1 in the past 30 days, most often from Nasdaq. For price context, ABUS is down 2.56% at $4.18. The most recent story, "After Hours Most Active for Sep 25, 2026 : FTXN, ABUS, FTXH, CMCSA, NVDA, CSCO, JPM, BMNR, EQT, CNP, PFE, CVS", was published by Nasdaq on Sep 25, 2026.
Headlines link to the original publishers. MetaCap does not republish third-party articles.
Summary generated from market data by MetaCap's automated system. Methodology